Table 2.
T Cell Based Therapy
| Clinical Trial Identifier | Phase | Interventions | Status |
|---|---|---|---|
| NCT04990557 | Phase 1/Phase 2 | PD-1 and ACE2 Knockout T Cells | Not yet recruiting |
| NCT04457726 | Phase 1/Phase 2 | SARS-CoV-2 Specific T Cells | Recruiting |
| NCT04765449 | Phase 1 | Cytotoxic T Lymphocytes | Not yet recruiting |
| NCT04401410 | Phase 1 | Biological: Partially HLA-matched SARS-CoVSTs | Recruiting |
| NCT04389385 | Phase 1 | Biological:COVID-19 Specific T Cell derived exosomes (CSTCExo) | Active, not recruiting |
| NCT04406064 | Phase 2 | Biological: Viral Specific T-cells(VSTs) | Withdrawn |
| NCT04578210 | Phase 1/Phase 2 | T memory cells and NK cells | Recruiting |
| NCT04468971 | Phase 1 | CK0802 | Active, not recruiting |
| NCT04737161 | Phase 1 | T regulatory cells | Withdrawn |